Stock Events

Mankind Pharma 

₹2,243.95
11
+₹3.35+0.15% Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
893.42B
P/E Ratio
46.73
Dividend Yield
-
Dividend
-

Earnings

29MayConfirmed
Q2 2023
Q4 2023
Q1 2024
9.62
10.17
10.72
11.27
Expected EPS
9.624764188597998
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MANKIND.NSE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. It also provides consumer healthcare products, such as condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. The company offers its products primarily under the Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar brand names. In addition, it engages in the trading and exporting of pharmaceutical and health care products; manufacturing of packing materials ayurvedic products, packing materials, bulk drugs, and consumer goods; real estate, leasing, and hospitality businesses; and provision of IT services. Mankind Pharma Limited was founded in 1986 and is based in New Delhi, India.
Show more...
CEO
Mr. Ramesh C. Juneja
Country
IN
ISIN
INE634S01028

Listings